2024-25 Guide to Medications for the Treatment of Diabetes Mellitus
The 2024-25 Guide to Medications for the Treatment of Diabetes Mellitus is a complete and newly revised reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide addresses all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Each discussion reflects the latest guidance of the American Diabetes Association’s Standards of Care in Diabetes. This guide also features chapters on medication management of comorbidities such as:
• Neuropathy
• Chronic Kidney Disease
• Retinopathy
• Hypoglycemia
• Obesity
• Depression
JOHN R. WHITE, JR., PA-C, PHARMD, is Chair and the R. Keith Campbell Distinguished Professor in Diabetes Care of the Department of Pharmacotherapy at Washington State University College of Pharmacy. Dr. White is the author of three books, more than 30 book chapters, and over 150 manuscripts on diabetes medications. He is currently Associate Editor of <i>Clinical Diabete</i>s.
